Testing vivo-morpholino mediated gene knockdown in threespine stickleback

This study demonstrates the potential of intraperitoneal vivo-morpholino injections for transient gene knockdown in adult threespine stickleback, achieving successful knockdown of the *Spi1b* gene in the spleen despite variable delivery efficiency across target organs.

The Gist

Imagine you have a very complex instruction manual for building a house (the fish's DNA). Sometimes, you want to see what happens if you temporarily hide a specific page of that manual to see if the house still stands or if a room stops getting built. In the world of science, this is called "gene knockdown."

This paper is about trying out a new way to hide those instruction pages in a specific type of fish called the threespine stickleback.

Here is the story of their experiment, broken down into simple concepts:

1. The Problem: The Fish is Too Old for the Old Trick

Scientists have a magic tool called a Morpholino (let's call it a "Gene Eraser"). It works great on baby fish (embryos) because you can inject it right when they are tiny, and it spreads everywhere.

However, the stickleback fish in this study are adults. If you try to use the old "baby" method on an adult, it doesn't work because the eraser can't get inside the cells. It's like trying to spray perfume into a sealed, locked safe; the scent just stays outside.

2. The Solution: The "Delivery Drone" (Vivo-Morpholino)

To solve this, the scientists used a special version of the eraser called a Vivo-Morpholino.

• The Analogy: Think of a standard Morpholino as a regular letter that gets stuck in the mailbox. The Vivo-Morpholino is like that same letter, but it's attached to a tiny, charged "delivery drone" (a dendimer). This drone helps the letter stick to the cell's door and push its way inside.
• The Goal: They wanted to see if they could inject this "drone" into the belly of an adult stickleback, have it travel to the organs (liver, spleen, intestine), and successfully hide the instructions for three specific genes involved in the fish's immune system.

3. The Experiment: The Three Targets

The scientists picked three genes they thought were important for how the fish fights off parasites (specifically tapeworms):

1. Spi1b: The "General" that orders the immune troops to build a wall (fibrosis).
2. STAT6: A "Messenger" that helps coordinate the immune response.
3. HNF4α: A "Manager" that controls liver functions.

They injected the "Gene Eraser" drones into the fish and waited 24 or 48 hours to see if the instructions for these genes disappeared.

4. The Results: A Mixed Bag

The results were a bit like a game of "Whack-a-Mole" where the moles only pop up sometimes:

• The Success: In the spleen (an organ like a blood filter), they successfully silenced the Spi1b gene. The instructions were hidden, and the gene's activity dropped by more than half. This proved the method could work.
• The Misses: In the liver and intestine, the results were messy. Sometimes the genes didn't get silenced at all. Sometimes, the "Gene Eraser" seemed to accidentally knock out the "housekeeping" genes (the genes that keep the cell alive) instead of the target.
• The Mystery: They also injected a glowing version of the eraser to see where it went. It was like watching a glow-in-the-dark paint spread. They saw the glow in all the organs, but it was very uneven. Sometimes the liver was glowing bright, sometimes the spleen was dark.

5. Why Did It Fail Sometimes?

The scientists realized the problem wasn't the "Gene Eraser" itself, but the delivery method.

• The Leak: They injected the fish into the belly cavity. It's possible the liquid leaked out of the injection hole before it could spread, or it didn't reach every cell evenly.
• The Timing: The "drone" might have worked quickly and then faded away, or it might have gotten stuck in one organ and never reached the others.

The Bottom Line

This paper is a proof-of-concept. It's like a pilot test for a new delivery service.

• Did it work? Yes, partially. They proved that you can inject adult stickleback with these special tools and silence genes in specific organs.
• Is it perfect? No. The delivery is currently inconsistent. Some fish got the medicine; others didn't.
• What's next? The scientists need to figure out how to make the "delivery drone" more reliable—maybe by changing the injection spot, the amount of liquid, or the temperature—so that in the future, they can study exactly how these genes control the fish's immune system without the guesswork.

In short: They built a new key to lock specific doors in an adult fish's body. The key works, but sometimes it gets lost in the hallway. Now they just need to figure out how to make sure the key always reaches the right door.

Technical Summary

1. Problem Statement

The threespine stickleback (Gasterosteus aculeatus) is a premier model organism for evolutionary and ecological genetics. While genomic tools (e.g., sequencing, QTL mapping) are well-established in this species, functional validation of candidate genes in vivo remains limited.

• Limitations of Current Methods: CRISPR/Cas9 and TALENs are effective but often require embryonic manipulation, which is difficult for genes essential for early development or those with lethal knockouts. Furthermore, the lack of commercial antibodies in stickleback hinders protein-level validation (Western blotting) for translation-blocking methods.
• The Gap: There is no established protocol for using vivo-morpholinos (vivo-MOs) in adult stickleback. Vivo-MOs are antisense oligonucleotides modified with an octa-guanidinium dendrimer that allow for transient, specific gene knockdown in adult organisms by blocking RNA splicing or translation. They offer a solution for studying essential genes and validating genomic findings without permanent genetic modification.

2. Methodology

The study aimed to establish a protocol for intraperitoneal (IP) injection of splice-blocking vivo-MOs in adult stickleback and assess their efficacy.

• Subjects: F1 hybrid stickleback (crosses between Boot Lake x Echo Lake populations) were used for knockdown experiments. F1 Sayward x Echo progeny were used for delivery validation.
• Target Genes: Three genes involved in the fibrotic immune response to parasitic tapeworms (Schistocephalus solidus) were selected:
  1. Spi1b: Encodes transcription factor PU.1 (pro-fibrotic).
  2. STAT6: Transcription factor regulating cytokines and fibrosis.
  3. HNF4α: Transcription factor regulating liver gene expression.
• Experimental Design:
  • Injection: Adult fish were anesthetized and injected intraperitoneally with 15 μL of 0.125 mM splice-blocking vivo-MOs (or a fluorescent control) using 31G insulin syringes.
  • Timepoints: Fish were dissected at 24 hours post-injection (hpi) and 48 hpi.
  • Tissue Sampling: Liver, spleen, and intestine were harvested.
  • Delivery Validation: A fluorescein-tagged control MO was injected into 12 fish. Organs were imaged via IVIS Spectrum at 24, 48, 72, and 96 hpi to track uptake and retention.
• Analysis:
  • Knockdown Assessment: RNA was extracted, converted to cDNA, and analyzed via semi-quantitative RT-PCR. Primers flanked the targeted splice junctions to detect exon skipping (shorter bands) or transcript degradation via Nonsense-Mediated Decay (NMD).
  • Quantification: Band intensities were quantified using ImageJ and compared to controls using t-tests.

3. Key Results

The study demonstrated that vivo-MOs can be delivered to stickleback organs but highlighted significant variability in knockdown efficiency.

• Successful Knockdown (Spi1b in Spleen):
  • At 24 hpi, a significant >50% reduction in Spi1b mRNA was observed in the spleen of injected fish compared to controls ($p < 0.0001$).
  • RT-PCR showed the wild-type band size remained, but intensity decreased, suggesting the truncated transcripts were degraded via NMD rather than accumulating as shorter bands.
• Variable/Inconsistent Results:
  • Liver: No significant knockdown was observed for any gene at 24 hpi.
  • Intestine (48 hpi): Complete absence of STAT6 and HNF4α bands was observed in some samples, but this was confounded by the death of several fish (leaving $N=1$) and the unexpected loss of housekeeping gene signals (Rpl13a, UBA52), suggesting potential off-target effects or uneven distribution.
  • STAT6 (Spleen): Unexpectedly, STAT6 expression increased 1.1-fold in the spleen, possibly indicating a compensatory mechanism.
• Delivery Validation (Fluorescent Control):
  • Fluorescence was detected in all target organs (liver, spleen, intestine) at all timepoints, confirming that the MOs successfully entered the tissues.
  • Inconsistency: Fluorescence intensity was highly variable between individuals and organs. The liver showed peak intensity at 24 hpi, while the spleen showed a peak at 96 hpi in only one sample. This variability in uptake and retention correlates with the inconsistent knockdown results.

4. Key Contributions

• Proof of Concept: This is the first study to demonstrate that intraperitoneal injection of vivo-MOs can successfully deliver oligonucleotides to adult stickleback organs and achieve transient gene knockdown.
• Methodological Protocol: The paper provides a foundational protocol for IP injection, tissue harvesting, and RT-PCR analysis specific to stickleback using splice-blocking MOs.
• Identification of Limitations: The study rigorously identifies that while delivery occurs, reproducibility is currently low due to variable cellular uptake and potential leakage at the injection site (a known issue with stickleback skin).

5. Significance and Future Directions

• Functional Genomics: This tool fills a critical gap in the stickleback research toolkit, allowing researchers to validate candidate genes identified in genomic studies (e.g., QTLs for immune response) without the ethical and technical hurdles of creating lethal knockouts in embryos.
• Optimization Needed: The authors conclude that while the method is viable, future studies must optimize delivery. Suggested improvements include:
  • Testing higher concentrations of MOs.
  • Exploring alternative delivery routes (e.g., intravenous or tissue-specific injections) to bypass the variability of IP uptake.
  • Refining housekeeping gene selection to avoid off-target effects on reference genes.
• Broader Impact: Success in stickleback could pave the way for using vivo-MOs in other emerging non-model fish species where embryonic manipulation is difficult or where adult-stage gene function is the primary research focus.